Lazard Asset Management LLC Uni Qure N.V. Transaction History

Lazard Asset Management LLC

$72.9 Billion
Q2 2024

A detailed history of Lazard Asset Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Lazard Asset Management LLC holds 129 shares of QURE stock, worth $828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129

Previous 1,958 93.41%

Holding current value

$828

Previous $10,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $8,029 - $9,931	-1,829 Reduced 93.41%	129 $0
Q1 2024 May 14, 2024	SELL	$4.82 - $6.93 $5,215 - $7,498	-1,082 Reduced 35.59%	1,958 $9,000
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $619 - $909	110 Added 3.75%	3,040 $20,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $899 - $1,585	134 Added 4.79%	2,930 $19,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $32,303 - $64,491	-2,905 Reduced 50.96%	2,796 $32,000
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $56,025 - $69,117	2,996 Added 110.76%	5,701 $114,000
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $34,554 - $52,099	-1,907 Reduced 41.35%	2,705 $61,000
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $194,098 - $291,947	-11,431 Reduced 71.25%	4,612 $86,000
Q2 2022 Aug 09, 2022	BUY	$13.15 - $20.45 $68,380 - $106,340	5,200 Added 47.96%	16,043 $298,000
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $110,998 - $164,131	7,634 Added 237.89%	10,843 $195,000
Q4 2021 Feb 09, 2022	SELL	$20.24 - $36.01 $56,631 - $100,755	-2,798 Reduced 46.58%	3,209 $65,000
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $53,242 - $78,236	2,047 Added 51.69%	6,007 $191,000
Q2 2021 Aug 12, 2021	BUY	$29.97 - $37.17 $60,599 - $75,157	2,022 Added 104.33%	3,960 $121,000
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $54,298 - $78,049	1,857 Added 2292.59%	1,938 $65,000
Q4 2020 Feb 11, 2021	BUY	$35.35 - $50.67 $1,484 - $2,128	42 Added 107.69%	81 $2,000
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $1,757 - $2,641	39 New	39 $1,000
Q3 2018 Nov 13, 2018	SELL	$29.75 - $43.08 $3.41 Million - $4.94 Million	-114,681 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$21.96 - $39.94 $629,900 - $1.15 Million	28,684 Added 33.35%	114,681 $4.33 Million
Q1 2018 May 14, 2018	BUY	$17.1 - $26.61 $1.47 Million - $2.29 Million	85,997 New	85,997 $2.02 Million

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Uni Qure N.V. Transaction History